Zalzal G H
George Washington University, Washington D.C., USA.
J Med Liban. 1994;42(4):230-4.
Adenotonsillar disease can be divided into two categories, infection and hypertrophy. They are closely related with low grade infection causing hypertrophy in most instances. Minor advances have been accomplished in the treatment of infectious processes, mainly the advent of new antibiotics. More important advances have occurred in the field of airway obstruction secondary to adenotonsillar hypertrophy. Currently there exists a significant body of knowledge on obstructive sleep apnea. With improvement in anesthetic and surgical techniques younger children are being treated earlier to relief airway obstruction. This manuscript describes current management of adenotonsillar disease.
腺样体扁桃体疾病可分为两类，即感染和肥大。在大多数情况下，它们与导致肥大的低度感染密切相关。在感染性疾病的治疗方面取得了一些小进展，主要是新抗生素的出现。在腺样体扁桃体肥大继发气道阻塞领域取得了更重要的进展。目前，关于阻塞性睡眠呼吸暂停已有大量的知识。随着麻醉和手术技术的改进，年幼患儿能够更早地接受治疗以缓解气道阻塞。本文描述了腺样体扁桃体疾病的当前治疗方法。
